Z-0128-2017 Class II Terminated
FDA device recall Z-0128-2017 was initiated by Becton, Dickinson And Company, BD Biosciences on Sep 21, 2016 and is designated Class II. Reason for recall: CD79b (SN8) PE is contaminated with a FITC conjugate of unknown antigenic specificity The recall status is terminated (terminated Dec 27, 2016). Affected quantity: 14 units.
Recall details
- Product Type
- Devices
- Report Date
- Oct 26, 2016
- Initiation Date
- Sep 21, 2016
- Termination Date
- Dec 27, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14 units
Product description
CD79b PE (ASR) , Catalog number 335816 ; Hematology: The CD79b antibody recognizes an epitope on the extracellular domain of a 3640 kilodalton (kDa) type I membrane glycoprotein. Immunoglobulin (Ig) antigen receptors are composed of a non-covalently associated complex of Ig and two other proteins, Iga and Igb, which have been designated as CD79a and CD79b, respectively. antigen
Reason for recall
CD79b (SN8) PE is contaminated with a FITC conjugate of unknown antigenic specificity
Distribution pattern
Nationwide Distribution to CA, MN, OH and TX.
Code information
Lot number: 5348570; Expiration Date: 31 July 2017
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0128-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026